drugset / Trial / NCT00712894

Effects of Different Vasodilators on Coronary No-reflow During primAry percuTaneous Coronary intErvention in Patients With Acute Myocardial Infarction

NCT00712894

Phase 4 Completed 102 enrolled Fudan University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of three different vasodilators including diltiazem, verapamil and nitroglycerin for reversal of no-reflow/slow-flow during direct percutaneous coronary intervention for acute myocardial infarction.

Timeline

Start
2006-12
Primary completion
2009-04
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Diltiazem Small molecule 400 ug Other
Subject Diltiazem Small molecule 2000 ug Other
Comparator Nitroglycerin Unknown 200 ug Other
Comparator Nitroglycerin Unknown 1000 ug Other
Comparator Verapamil Other / unclassified 200 ug Other
Comparator Verapamil Other / unclassified 1000 ug Other